ABVXAbivaxABVX info
$11.35info-1.13%24h
Global rank9436
Market cap$714.11M
Change 7d-3.07%
YTD Performance8.30%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Abivax (ABVX) Stock Overview

    ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.

    ABVX Stock Information

    Symbol
    ABVX
    Address
    7-11 boulevard HaussmannParis, 75009France
    Founded
    -
    Trading hours
    -
    Website
    https://www.abivax.com
    Country
    🇫🇷 France
    Phone Number
    33 1 53 83 09 63

    Abivax (ABVX) Price Chart

    -
    Value:-

    Abivax Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $11.35
    N/A
    Market Cap
    $714.11M
    N/A
    Shares Outstanding
    62.92M
    N/A
    Employees
    26.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org